PaloBiofarma

About:

Innovation Through Medicinal Chemistry

Website: http://www.palobiofarma.com

Top Investors: European Innovation Council, Inveready, SODENA, The Foundation for Prader-Willi Research, Fitalent

Description:

Palobiofarma is a Spanish Biotech company located in Barcelona’s Science Park. Our mission is to discover and develop new drugs based on the modulation of the adenosine receptors. Our vision is to be the first european adenosine drug discovery company

Total Funding Amount:

16M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2005-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-02-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai